Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PRL3-zumab, a first-in-class humanized antibody for cancer therapy.
Thura M, Al-Aidaroos AQO, Yong WP, Kono K, Gupta A, Lin YB, Mimura K, Thiery JP, Goh BC, Tan P, Soo R, Hong CW, Wang L, Lin SJ, Chen E, Rha SY, Chung HC, Li J, Nandi S, Yuen HF, Zhang SD, Guan YK, So J, Zeng Q. Thura M, et al. Among authors: hong cw. JCI Insight. 2016 Jun 16;1(9):e87607. doi: 10.1172/jci.insight.87607. JCI Insight. 2016. PMID: 27699276 Free PMC article.
Awaiting a new era of cancer immunotherapy.
Hong CW, Zeng Q. Hong CW, et al. Cancer Res. 2012 Aug 1;72(15):3715-9. doi: 10.1158/0008-5472.CAN-12-0063. Epub 2012 Jul 19. Cancer Res. 2012. PMID: 22815525 Review.
Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia.
Park JE, Yuen HF, Zhou JB, Al-Aidaroos AQ, Guo K, Valk PJ, Zhang SD, Chng WJ, Hong CW, Mills K, Zeng Q. Park JE, et al. Among authors: hong cw. EMBO Mol Med. 2013 Sep;5(9):1351-66. doi: 10.1002/emmm.201202183. Epub 2013 Aug 8. EMBO Mol Med. 2013. PMID: 23929599 Free PMC article.
190 results